ROR2 通过破坏蛋白质稳态驱动右心室心力衰竭
该研究在新生大鼠心室肌细胞中过表达或敲低 ROR2,并在小鼠中通过 AAV9 介导的过表达或短发夹 RNA 敲低进行验证。结果显示,ROR2 破坏蛋白质翻译与折叠的协调,导致泛素蛋白酶体系统过度清除蛋白,损害肌节和细胞骨架结构与功能。抑制泛素蛋白酶体或恢复伴侣蛋白表达可部分挽救心肌细胞结构与收缩缺陷,提示 ROR2 是右心室衰竭的驱动因素和潜在治疗靶点。
要点
- ROR2 上调与右心室衰竭严重程度相关。
- 抑制泛素蛋白酶体或恢复伴侣蛋白表达可部分逆转 ROR2 诱导的心肌细胞缺陷。
- ROR2 可能成为右心室衰竭的治疗靶点。
核心结论
- ROR2 通过破坏蛋白质稳态驱动右心室衰竭,是潜在的治疗靶点。
研究设计与样本
- 在新生大鼠心室肌细胞中过表达或敲低 ROR2,并进行共聚焦显微镜、RNA 测序、蛋白质组学、蛋白质稳态功能分析和起搏评估。
- 在小鼠中通过 AAV9 介导的过表达或短发夹 RNA 敲低 ROR2,采用肺动脉环缩压力负荷模型诱导右心室衰竭。
- 对 ROR2 修饰小鼠进行超声心动图、组织学以及右心室蛋白合成和蛋白酶体容量评估。
主要发现
- 在新生大鼠心室肌细胞中,ROR2 显著干扰蛋白质翻译与折叠之间的协调。
- 上述失衡导致泛素蛋白酶体系统对蛋白的清除过度增加,并对肌节和细胞骨架结构与功能造成显著影响。
- 抑制泛素蛋白酶体系统或恢复伴侣蛋白表达足以部分挽救 ROR2 诱导的心肌细胞结构和收缩缺陷。
- 在小鼠中,强制心脏 ROR2 表达足以破坏蛋白质稳态并驱动右心室衰竭。
- 在压力负荷右心室衰竭模型中,ROR2 敲低可部分挽救蛋白质稳态以及右心室结构和功能。
临床怎么用
- ROR2 可作为右心室衰竭的潜在干预靶点。
- 恢复伴侣蛋白表达或抑制泛素蛋白酶体系统可能对 ROR2 相关右心室衰竭有部分治疗作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: No therapies exist to reverse right ventricular failure (RVF), and the molecular mechanisms that drive RVF remain understudied. We recently reported that the developmentally restricted noncanonical WNT receptor ROR2 (receptor tyrosine kinase-like orphan receptor 2) is upregulated in human RVF in proportion to severity of disease. Here we test the mechanistic role of ROR2 in RVF pathogenesis. METHODS: ROR2 was overexpressed or knocked down in neonatal rat ventricular myocytes and then characterized using confocal microscopy, RNA sequencing, proteomics, proteostatic functional assays, and pacing to assess contractile properties. The impact of cardiac ROR2 expression was evaluated in mice by AAV9-mediated overexpression and by AAV9-mediated delivery of short hairpin RNA to knockdown ROR2 in a pulmonary artery banded pressure overload model of RVF. ROR2-modified mice were evaluated by echocardiography, histology, and right ventricle protein synthesis and proteasome capacity. RESULTS: In neonatal rat ventricular myocytes, we find that ROR2 profoundly dysregulates the coordination between protein translation and folding. This imbalance leads to excess protein clearance by the ubiquitin proteasome system with dramatic impacts on sarcomere and cytoskeletal structure and function. Inhibiting the ubiquitin proteasome system or restoring chaperone expression is sufficient to partially rescue ROR2-induced structural and contractile deficits in cardiomyocytes. In mice, forced cardiac ROR2 expression is sufficient to disrupt proteostasis and drive RVF, whereas conversely Ror2 knockdown partially rescues proteostasis and right ventricle structure and function in a pressure overload model of RVF. CONCLUSIONS: In sum, ROR2 is a key driver of RVF pathogenesis through proteostatic disruption and thus provides a promising target to treat RVF.
引用
- Hartman, Uy, Uchida, et al. ROR2 Drives Right Ventricular Heart Failure Through Disruption of Proteostasis. Circulation. 2026. PMID: 42934204. doi:10.1161/CIRCULATIONAHA.125.078798
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。